Medline (MDLN) Depreciation & Amortization (CF) (2025 - 2026)
Medline's (MDLN) quarterly Depreciation & Amortization (CF) came in at $254.0 million in Q1 2026, up 2.83% year-on-year from $247.0 million in Q1 2025, and up 2.83% on a QoQ basis from $247.0 million in Q1 2025.
Medline (MDLN) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
Medline (MDLN) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $254.0 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 2.83% year-over-year to $254.0 million in Q1 2026; TTM through Mar 2026 was $501.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 3.48% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $254.0 million, up from $247.0 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for MDLN reached as high as $254.0 million in Q1 2026 and fell as low as $247.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 563.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 254.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 58.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 135.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 56.55 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 237.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 254.00 Mn |
| Mar 28, 2026 | 254.00 Mn |
| Mar 29, 2025 | 247.00 Mn |
| Mar 29, 2025 | 247.00 Mn |